BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  iCAD Responds to CMS’ Finalized Radiation Oncology Alternative Payment Model IORT reimbursement unchanged; payment values for alternative, longer courses of radiation therapy reduced

  iCAD, Inc. is providing additional comments following the Centers for Medicare & Medicaid Services’ publication of a new Innovation Center model designed, according to CMS, to improve the quality of care for cancer patients receiving radiotherapy and reduce Medicare expenditures through bundled payments.

  September 20, 2020

   · 

  8 min read
• Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain

  Shanghai SIMR Biotechnology Co., Ltd. announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been successfully dosed.

  September 20, 2020

   · 

  2 min read